Viva Biotech Holdings (VB0) — Free Cash Flow Generation Index
Viva Biotech Holdings (VB0) has a Free Cash Flow Generation Index of 1.32x as of June 2023. Free cash flow of €209.53 Million represents 1% of operating cash flow (€158.72 Million). Explore Viva Biotech Holdings (VB0) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Viva Biotech Holdings Free Cash Flow Generation Index (2016–2024)
Historical FCF Generation Index trend for Viva Biotech Holdings across 9 annual periods. For the full cash flow conversion analysis, see VB0 cash flow conversion.
Annual Free Cash Flow Generation for Viva Biotech Holdings (2016–2024)
Year-by-year Free Cash Flow Generation Index for Viva Biotech Holdings. Check Viva Biotech Holdings total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.49x | €182.32 Million | €373.99 Million | €191.67 Million | ▼ -4.4% |
| 2023 | 0.51x | €195.57 Million | €383.40 Million | €187.84 Million | ▲ +44.3% |
| 2022 | 0.35x | €136.51 Million | €386.05 Million | €249.33 Million | ▲ +105.6% |
| 2021 | -6.28x | €-488.49 Million | €77.83 Million | €565.18 Million | ▲ +53.7% |
| 2020 | -13.56x | €-585.70 Million | €43.18 Million | €592.62 Million | ▼ -3846.2% |
| 2019 | -0.34x | €-15.81 Million | €46.01 Million | €56.19 Million | ▲ +88.0% |
| 2018 | -2.87x | €-34.79 Million | €12.11 Million | €46.90 Million | ▼ -993.5% |
| 2017 | 0.32x | €8.97 Million | €27.89 Million | €18.92 Million | ▼ -76.1% |
| 2016 | 1.35x | €28.46 Million | €21.12 Million | €7.34 Million | — |